Pfizer (PFE) News Today → How Biden has already won 2024 (From Porter & Company) (Ad) Free PFE Stock Alerts $28.64 -0.28 (-0.97%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 19 at 3:30 PM | marketbeat.comRobeco Institutional Asset Management B.V. Has $60.74 Million Holdings in Pfizer Inc. (NYSE:PFE)Robeco Institutional Asset Management B.V. cut its holdings in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 51.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,109,572 shares of the biopharmaceMay 19 at 7:07 AM | marketbeat.comPfizer Q1 Earnings TranscriptMay 19 at 6:51 AM | fool.comBillionaires Are Buying These High-Yield Dividend Stocks Left and Right. Should You Follow Their Lead?May 19 at 4:22 AM | americanbankingnews.comPfizer (NYSE:PFE) Trading Down 1.3%May 18 at 10:18 PM | marketbeat.comPfizer Inc. (NYSE:PFE) Shares Purchased by AMG National Trust BankAMG National Trust Bank boosted its holdings in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 71.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 151,275 shares of the biopharmaceutical company'sMay 17 at 5:41 PM | reuters.comPfizer wins $107.5 million from AstraZeneca in US cancer drug patent trialMay 17 at 2:48 PM | marketbeat.comPfizer (NYSE:PFE) Stock Price Down 1.3%Pfizer (NYSE:PFE) Stock Price Down 1.3%May 17 at 1:27 PM | marketbeat.comPfizer Inc. (NYSE:PFE) Shares Sold by Exchange Capital Management Inc.Exchange Capital Management Inc. lessened its stake in Pfizer Inc. (NYSE:PFE - Free Report) by 51.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 34,548 shares of the biopharmaceutical compaMay 17 at 1:06 PM | yahoo.comHow the love story between von der Leyen and Pfizer turned sourMay 17 at 1:06 PM | seekingalpha.comPfizer Stock: Rebound Has Started (Technical Analysis)May 17 at 1:06 PM | finance.yahoo.comMarket Chatter: Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTechMay 17 at 12:00 PM | reuters.comModerna wins case in patent dispute with Pfizer, BioNTech over COVID shot, FT reportsMay 17 at 7:11 AM | investorplace.com7 Value Stocks to Buy and Hold for a Decade of DominanceMay 17 at 12:00 AM | seekingalpha.comPfizer: Potential Double-Digit Upside Combined With High Dividend YieldMay 16 at 10:36 PM | marketbeat.comPfizer Inc. (NYSE:PFE) Shares Sold by Oxbow Advisors LLCOxbow Advisors LLC reduced its holdings in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 90.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,558 shares of the biopharmaceutical company's stock after seMay 16 at 4:42 PM | marketbeat.comPfizer (NYSE:PFE) Shares Down 0.1% Pfizer (NYSE:PFE) Stock Price Down 0.1%May 16 at 9:45 AM | fool.com2 Top Growth Stocks Down 24% and 50% to Buy With $100May 16 at 7:15 AM | investorplace.com7 Pharma Stocks Harnessing AI Brainpower for Big BreakthroughsMay 16 at 7:03 AM | msn.comPfizer Settles Zantac Lawsuits, Agrees To $250M Settlement To Reduce Liability: ReportMay 16 at 7:03 AM | msn.comPfizer agrees to pay up to $250M to settle Zantac cancer lawsuits - reportMay 16 at 2:02 AM | yahoo.comPfizer offers up to $250 million to settle thousands of Zantac cancer lawsuits, FT reportsMay 16 at 2:02 AM | finance.yahoo.comPfizer offers up to $250 million to settle Zantac cancer lawsuits, FT reportsMay 16 at 2:02 AM | finance.yahoo.comUPDATE 1-Pfizer offers up to $250 mln to settle Zantac cancer lawsuits, FT reportsMay 16 at 12:12 AM | reuters.comPfizer offers up to $250 mln to settle thousands of Zantac cancer lawsuits, FT reportsMay 16 at 12:10 AM | marketbeat.comPfizer Inc. (NYSE:PFE) Shares Sold by Ceera Investments LLCCeera Investments LLC lowered its stake in Pfizer Inc. (NYSE:PFE - Free Report) by 46.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,903 shares of the biopharmaceutical company's stock aftMay 15, 2024 | marketbeat.comPfizer (NYSE:PFE) Stock Price Up 1%Pfizer (NYSE:PFE) Trading Up 1%May 15, 2024 | msn.comPfizer, Freeport-McMoRan, Vertex Pharmaceuticals And A Major Tech Stock On CNBC's 'Final Trades'May 15, 2024 | seekingalpha.comPfizer: Best Trading Momentum Since 2021 And 6% YieldMay 15, 2024 | fool.com3 No-Brainer Stocks to Buy With $500 Right NowMay 14, 2024 | marketbeat.comPfizer Inc. (NYSE:PFE) Stock Holdings Reduced by Wade G W & Inc.Wade G W & Inc. lowered its position in Pfizer Inc. (NYSE:PFE - Free Report) by 12.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 354,188 shares of the biopharmaceutical company's stockMay 14, 2024 | marketbeat.comPfizer (NYSE:PFE) Trading Down 0.1%Pfizer (NYSE:PFE) Stock Price Down 0.1%May 14, 2024 | fool.com2 Healthcare Stocks to Buy and Hold for Great Long-Term PotentialMay 13, 2024 | marketbeat.comPfizer (NYSE:PFE) Trading Up 2.1%Pfizer (NYSE:PFE) Shares Up 2.1%May 13, 2024 | finance.yahoo.comThe Zacks Analyst Blog Highlights Amazon, Visa, Pfizer, Martin Marietta Materials and Zimmer BiometMay 13, 2024 | msn.comPfizer’s next move: Can it break above $30?May 13, 2024 | prnewswire.comAstellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual MeetingMay 13, 2024 | marketbeat.com3 Stocks That Suddenly Drew in Options TradersOptions are complicated and not for the faint of heart. While some investors may use them to take on irresponsible leverage levels on their minor positions, others could use them to express their predictions on a particular stock.May 13, 2024 | marketbeat.com3 Stocks That Suddenly Drew in Options Traders (PFE)Three discounted stocks caught the attention of call option buyers last week, and they have Wall Street analysts to back them through double-digit upside.May 13, 2024 | msn.com'Seems Low:' Elon Musk Questions Pfizer's $0 Tax Bill, But Did Tesla Pony Up To Uncle Sam?May 13, 2024 | fool.comWant $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer StockMay 12, 2024 | marketbeat.comMassachusetts Financial Services Co. MA Acquires 8,298,920 Shares of Pfizer Inc. (NYSE:PFE)Massachusetts Financial Services Co. MA lifted its holdings in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 13.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 68,506,441 shares ofMay 12, 2024 | seekingalpha.comPfizer's Bottom May Be Here - Its Rich Yield Is TemptingMay 12, 2024 | reuters.comPfizer and AstraZeneca announce new investments of nearly $1 billion in FranceMay 12, 2024 | americanbankingnews.comPfizer (NYSE:PFE) Stock Price Down 0.5%May 11, 2024 | marketbeat.comDimensional Fund Advisors LP Has $1.21 Billion Position in Pfizer Inc. (NYSE:PFE)Dimensional Fund Advisors LP trimmed its position in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 7.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 41,974,387 shares of the biopharmaceutical company's stock aMay 11, 2024 | finance.yahoo.comPfizer Inc. Just Beat EPS By 61%: Here's What Analysts Think Will Happen NextMay 11, 2024 | marketbeat.comPrincipal Securities Inc. Makes New Investment in Pfizer Inc. (NYSE:PFE)Principal Securities Inc. purchased a new stake in Pfizer Inc. (NYSE:PFE - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 83,109 shares of the biopharmaceutical company's stock, valued at approximately $2May 10, 2024 | marketbeat.comPfizer (NYSE:PFE) Trading Down 0.5%Pfizer (NYSE:PFE) Stock Price Down 0.5%May 10, 2024 | barrons.comA Struggling Pfizer Looks for Help From a Wall StreeterMay 10, 2024 | fool.com2 Beaten-Down Stocks to Buy and Hold for 10 Years Get Pfizer News Delivered to You Automatically Sign up to receive the latest news and ratings for PFE and its competitors with MarketBeat's FREE daily newsletter. Email Address [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. PFE Media Mentions By Week PFE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PFE News Sentiment▼0.410.42▲Average Medical News Sentiment PFE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PFE Articles This Week▼4235▲PFE Articles Average Week Get Pfizer News Delivered to You Automatically Sign up to receive the latest news and ratings for PFE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Bristol-Myers Squibb News Zoetis News AbbVie News Merck & Co., Inc. News Johnson & Johnson News Abbott Laboratories News Sanofi News Novartis News Regeneron Pharmaceuticals News Vertex Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:PFE) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyUrgent Nvidia WarningAltimetryMost important medical advance in 100 yearsThe Oxford ClubMissed NVDA? Buy this AI stock NOWChaikin Analytics41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pfizer Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
